Hetero Trustiva Tablets is a fixed-dose combination medication used in the treatment of HIV/AIDS. These are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older weighing at least 40 kg. It contains three active ingredients: efavirenz, emtricitabine, and tenofovir disoproxil fumarate. This contains three different antiretroviral drugs, each with a unique mechanism of action. Emtricitabine and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors (NRTIs) that work by interfering with the enzyme reverse transcriptase, thereby preventing the conversion of viral RNA into DNA. Hetero Trustiva Tablets are used as part of combination antiretroviral therapy (ART) for the management of HIV/AIDS.
Specification
Brand |
Trustiva |
Manufacturer |
Hetero |
Packaging Size |
30 Tablets |
Packaging Type |
Bottle |
Strength |
300 mg |